Bruker Co. (NASDAQ:BRKR – Get Rating) announced a quarterly dividend on Monday, May 15th, Zacks reports. Investors of record on Thursday, June 1st will be given a dividend of 0.05 per share by the medical research company on Friday, June 16th. This represents a $0.20 dividend on an annualized basis and a dividend yield of […]
Bruker (NASDAQ:BRKR – Get Rating) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Wednesday. BRKR has been the subject of a number of other reports. UBS Group increased their target price on Bruker from $92.00 to $98.00 in […]
Bruker Co. (NASDAQ:BRKR – Get Rating) CEO Frank H. Laukien sold 89,018 shares of the business’s stock in a transaction on Monday, May 8th. The shares were sold at an average price of $77.05, for a total transaction of $6,858,836.90. Following the sale, the chief executive officer now directly owns 38,210,993 shares of the company’s […]
Bruker (NASDAQ:BRKR – Get Rating) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $2.55-$2.60 for the period, compared to the consensus estimate of $2.56. The company issued revenue guidance of $2.83 billion-$2.88 billion, compared to the consensus revenue estimate of $2.82 billion. […]
Bruker (NASDAQ:BRKR – Get Rating) updated its FY23 earnings guidance on Thursday. The company provided earnings per share guidance of $2.55-2.60 for the period, compared to the consensus earnings per share estimate of $2.56. The company issued revenue guidance of $2.83-2.88 billion, compared to the consensus revenue estimate of $2.83 billion. Bruker also updated its […]